Stem Cell Therapy for Diabetes

The treatment of patients with diabetes mellitus may greatly benefit from the use of undifferentiated or undeveloped cells. The developmental stages and transcription factors involved in this process have been defined by research on the capacity of human embryonic undifferentiated cells to segregate into islet cells. In any event, ethical considerations as well as the possibility for teratoma formation limit the clinical applications of human embryonic stem cells.

 

  • Umbilical cord stem cells
  • Diabetes type 2
  • Bone marrow

Related Conference of Stem Cell Therapy for Diabetes

July 29-30, 2025

15th World Congress on Endocrinology and Diabetes

Paris, France
September 08-09, 2025

3rd World congress and Expo on Diabetes

Frankfurt, Germany
October 27-28, 2025

5th World Congress on Endocrine and Diabetes

Madrid, Spain
October 30-31, 2025

5th Annual Summit on Diabetes and Endocrinology

Paris, France
November 03-04, 2025

34th European Diabetes Congress

Rome, Italy
November 06-07, 2025

8th Annual Meeting on Diabetes and Endocrinology

Dubai, UAE
November 20-21, 2025

21st World Congress on Endocrinology & Diabetes

Paris, France
November 24-25, 2025

6th International conference on Diabetic complications

Barcelona, Spain
February 23-24, 2026

19th International Summit on Diabetes

London, UK
March 26-27, 2026

7th Global summit on Diabetes and Endocrinology

Amsterdam, Netherlands
May 18-19, 2026

57th Annual Congress on Endocrinology and Diabetes Research

Aix-en-Provence, France

Stem Cell Therapy for Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in